INTRODUCTION
============

Metabolic syndrome is a major risk factor for type 2 diabetes mellitus and cardiovascular disease. Specifically, it increases the risk of incidence of type 2 diabetes mellitus by 3.53- to 5.17-fold[@b1-jomes-27-166],[@b2-jomes-27-166] and that of the incidence of cardiovascular disease by 1.53- to 2.18-fold.[@b3-jomes-27-166] Furthermore, metabolic syndrome increases all-cause mortality by 1.27- to 1.60-fold.[@b4-jomes-27-166] To promote public health and reduce mortality incidence, the establishment of management practices for metabolic syndrome is important. However, factors of metabolic syndrome vary according to definition, and whether metabolic syndrome is a disease sharing a pathogenesis remains unclear.[@b5-jomes-27-166] As a result of these limitations, there is no consistent treatment recommendation. To elucidate the pathophysiology of metabolic syndrome, it could be helpful to understand the incidence differences of metabolic syndrome depending on the combination of individual factors of metabolic syndrome and to clarify if there is a discrepancy between the expected and actual prevalence of metabolic syndrome with a certain combination of individual factors. The combination of individual factors that increases the actual prevalence compared with the expected prevalence is defined as clustering.[@b6-jomes-27-166]

The aims of this study were to analyze the most influential factor related to the incidence of metabolic syndrome, to assess the clustering factors of metabolic syndrome, and to identify the pathogenesis of metabolic syndrome. The data were collected from responses to a health interview and nutrition surveys as well as the findings of health examinations.[@b7-jomes-27-166]

METHODS
=======

Study subjects
--------------

Subjects from the Korea National Health and Nutrition Examination Survey (KNHANES) VI were used in the present study. The KNHANES VI was conducted by the Division of Chronic Disease Surveillance of the Korean Centers for Disease Control and Prevention in 2013 and includes nationally representative data. Subjects of the KNHANES VI who were aged older than 20 years numbered 2,592 men and 3,376 women. After excluding subjects without metabolic data (waist circumference, systolic and diastolic blood pressure, fasting plasma glucose concentration, triglyceride concentration, and high-density lipoprotein cholesterol \[HDL-C\] concentration) and health behavior data (smoking status, exercise, and alcohol drinking), the present study considered 2,101 men and 2,831 women. The Institutional Review Board of the Korea Centers for Disease Control and Prevention had previously reviewed and approved the KNHANES (IRB No. 2013-07CON-03-4C), and the need for informed consent for the current study was waived.

Definition of metabolic syndrome
--------------------------------

Metabolic syndrome was defined according to the 2005 modified Adult Treatment Panel III by the American Heart Association and the National Heart, Lung, and Blood Institute.[@b8-jomes-27-166] The criteria of abdominal obesity included a circumference ≥90 cm for men and ≥85 cm for women according to the Korean definition of abdominal obesity.[@b9-jomes-27-166] Metabolic syndrome was diagnosed when three or more of the following were present: (1) waist circumference ≥90 cm for men and ≥85 cm for women; (2) systolic blood pressure ≥130 mmHg, diastolic blood pressure ≥85 mmHg, or antihypertensive medication use; (3) fasting plasma glucose concentration ≥100 mg/dL or antidiabetic medication use; (4) triglyceride concentration ≥150 mg/dL or anti-dyslipidemic medication use; (5) HDL-C concentration \<40 mg/dL for men and \<60 mg/dL for women or anti-dyslipidemic medication use.

Definition of clustering
------------------------

The expected prevalence was calculated by multiplying the prevalence of each risk factor based on its incidence in the study subjects. A ratio of observed prevalence to expected prevalence \>1 was defined as demonstrating clustering.[@b6-jomes-27-166]

Health behaviors
----------------

Information of health behaviors was obtained from responses to the questionnaires included in the KNHANES VI. Furthermore, the statuses of smoking, exercise, alcohol drinking, and perceived stress were analyzed. Smoking status was classified as either current smoker, ex-smoker, or nonsmoker. Exercise status was divided into three categories (none, three or fewer times a week, and more than four times a week). Alcohol drinking was classified according to the frequency of drinking per week, while perceived stress was classified according to degree.

Statistical analysis
--------------------

A complex, stratified, multistage sampling design was used to analyze the data from the KNHANES VI according to the statistics from the Korea Centers for Disease Control and Prevention. Ordinary regression analysis was used to determine the relationships between health behaviors and metabolic factors and the number of metabolic factors. Logistic regression was used to identify the influence of health behaviors and metabolic factors on the occurrence of metabolic syndrome and clustering effects of metabolic factors in metabolic syndrome.

RESULTS
=======

Characteristics of the study subjects
-------------------------------------

A total of 2,101 men and 2,831 women aged older than 20 years were included in this study. Most participants were between 40 and 59 years of age. The smoking status differed between the sexes; among men, the percentage of current smoker status was 40.1%, which was the most common, while among women, nonsmokers made up 84.3% of the population. The proportion of respondents exercising over four days per week was 21.5% for men and 26.1% for women. Additionally, the rates of drinking alcohol more than twice a week were 33.0% for men and 11.5% for women, while the rate of perceived severe stress was 21.7% for men and 26.1% for women. In men, high serum triglyceride concentration was the most common metabolic risk factor versus abdominal obesity in women. The prevalence of metabolic syndrome was 23.3% and 20.5% in men and women, respectively ([Table 1](#t1-jomes-27-166){ref-type="table"}).

Relationships among health behaviors, metabolic factors, and number of metabolic factors
----------------------------------------------------------------------------------------

In women, health behaviors were not associated with increasing numbers of metabolic factors; however, in men, the number of metabolic factors was associated with current smoker status and alcohol consumption more than twice per week. The relationships between metabolic factors and number of metabolic factors were similar in the sexes. All metabolic factors were associated with an increasing number of metabolic factors and, among them, high triglyceride concentration was most related in both men and women ([Table 2](#t2-jomes-27-166){ref-type="table"}).

The influence of health behaviors and metabolic factors on prevalence of metabolic syndrome
-------------------------------------------------------------------------------------------

The relationship of health behaviors and the prevalence of metabolic syndrome differed between men and women. In men, drinking alcohol more than twice per week was related with prevalence of metabolic syndrome compared to exercise in women. The relationship between metabolic factors and metabolic syndrome prevalence was comparable in both men and women; a high triglyceride concentration was most associated with prevalence of metabolic syndrome ([Table 3](#t3-jomes-27-166){ref-type="table"}).

The clustering effects of metabolic factors in metabolic syndrome
-----------------------------------------------------------------

[Table 4](#t4-jomes-27-166){ref-type="table"} shows the clustering effects of metabolic factors in metabolic syndrome. The clustering effect was observed with more than three metabolic factors. In men, the clustering effect of three metabolic factors appeared in three combinations. The first combination was abdominal obesity, hypertension, and hypertriglyceridemia; the second combination was abdominal obesity, hypertriglyceridemia, and low HDL-C concentration; and the third combination was hypertension, hyperglycemia, and hypertriglyceridemia. The clustering effect in men was strongest for the third combination. In women, the clustering effect of three metabolic factors was observed for two combinations. The first combination was abdominal obesity, hypertension, and hypertriglyceridemia, while the second combination was abdominal obesity, hypertriglyceridemia, and low HDL-C concentration. The clustering effect in women was stronger for the second combination. The clustering effect of four metabolic factors was observed in all combinations in women but was not observed in combinations not including hypertriglyceridemia in men.

DISCUSSION
==========

Clustering is defined as a situation in which the actual prevalence of disease according to individual risk factors is higher than the expected prevalence according to the same individual risk factors.[@b5-jomes-27-166] Metabolic syndrome, which is presented as a co-occurrence of metabolic risk factors for both type 2 diabetes mellitus and cardiovascular disease, is a representative clustering disease, with its pathogenesis based on insulin resistance.[@b10-jomes-27-166] Hyperinsulinemia appearing in response to insulin resistance may play a key role in the occurrence of hypertension, high low-density lipoprotein cholesterol concentration, low HDL-C concentration, and type 2 diabetes mellitus. Insulin resistance is associated with lower adiponectin, which reduces serum free fatty acid concentration and inflammation.[@b11-jomes-27-166] The aim of this study was to investigate the role of health behaviors and metabolic factors in the development of metabolic syndrome and to evaluate the clustering effect of metabolic risk factors.

In the present study, among several health behaviors, drinking alcohol was significantly associated with an increase in metabolic risk factors in men. Notably, the metabolic risk factors increased in men who drank more than twice a week. In a previous study[@b12-jomes-27-166], the rates of abdominal obesity and serum concentration of HDL-C were higher in participants with an alcohol consumption \>200 g per week versus in those with a lower level of alcohol consumption. In other words, alcohol consumption was a risk factor for abdominal obesity but not for cholesterol metabolism. Separately, a meta-analysis[@b13-jomes-27-166] reported that the risk of metabolic syndrome was lower in very light drinkers (0.1--5 g/day) versus in nondrinkers; however, the risk of metabolic syndrome was higher in heavy drinkers than in nondrinkers. In subgroup analysis, this J-shaped trend was remarkable in men but not in women. Unlike in previous studies, the J-shaped relationship between amount of alcohol consumption and number of metabolic risk factors was not observed in this study, which is probably due to our method of categorization of alcohol consumption. By increasing the risk of metabolic factors, including blood pressure, glucose metabolism, hypertriglyceridemia, and abdominal obesity, alcohol drinking increased the risk of metabolic syndrome.[@b14-jomes-27-166],[@b15-jomes-27-166] In this study, the relationship was observed only in men and was not concordant with the findings of previous studies because of the low prevalence of alcohol consumption in women.

On the other hand, exercising more than four times a week decreased the number of metabolic risk factors and the prevalence of metabolic syndrome in women but not in men. A disparity of sex in the relationship between physical activity and metabolic syndrome has been reported previously.[@b16-jomes-27-166] Another study[@b17-jomes-27-166] reported that rigorous physical activity decreased the risk of metabolic syndrome in both sexes, but that moderate physical activity decreased the risk of metabolic syndrome only in women. The mechanism of this disparity was explained by the existing biological differences in men and women.[@b18-jomes-27-166]--[@b20-jomes-27-166] Specifically, the amounts of fat, free fatty acids, and intramuscular fat are higher in women than in men; however, the amount of skeletal muscle mass is two-thirds lower in women than in men.[@b21-jomes-27-166] Furthermore, the total physical activity of women was less than that of men. Thus, it is anticipated that insulin resistance is stronger in women than in men.[@b22-jomes-27-166] However, the insulin sensitivity values of men and women were similar in a previous study.[@b23-jomes-27-166] Despite the sex variations in total physical activity and body composition, glucose disposal was similar between men and women. This result might be the result of enhanced glucose effectiveness in women. In women, glucose homeostasis is somewhat influenced by maintenance of serum estrogen within a narrow range. Therefore, in postmenopausal women, this effect disappears.[@b21-jomes-27-166],[@b22-jomes-27-166]

In this study, hypertriglyceridemia was the metabolic factor most associated with prevalence of metabolic syndrome in both sexes. In a previous study[@b23-jomes-27-166], hypertriglyceridemia (≥150 mg/dL) was suggested as a criterion for distinguishing prediabetes subjects according to risk of metabolic and cardiovascular diseases. The prediabetic subjects were insulin-resistant, and their risk of metabolic and cardiovascular diseases ranged broadly; therefore, criteria to assess the risk of metabolic and cardiovascular diseases are needed. Similar to our study, hypertriglyceridemia was proposed as a criterion based on its relationship with metabolic risk. In the current study, we analyzed the prevalence of metabolic syndrome for each metabolic risk factor and observed that the prevalence of metabolic syndrome was much higher in subjects with hypertriglyceridemia than in subjects with other risk factors for both sexes. As a result, we suggested that hypertriglyceridemia was the most useful indicator of insulin resistance due to its role in the pathogenesis of metabolic syndrome versus the other metabolic risk factors. In other words, reducing serum triglyceride concentration may reduce metabolic risk.

The influence of hypertriglyceridemia was also apparent in the clustering effect of metabolic risk factors for metabolic syndrome. A clustering effect was not observed in cases of one or two risk factors because the expected prevalence of metabolic syndrome was not higher than the actual prevalence. This was a predictable result because the diagnostic criteria for metabolic syndrome require three or more risk factors. Therefore, the clustering effect, where the actual prevalence was higher than the expected prevalence, was observed in groups with more than four risk factors except in the case of one combination of risk factors. The clustering effect was observed only with the combination of four risk factors including hypertriglyceridemia in men; thus, hypertriglyceridemia influenced the prevalence of metabolic syndrome more in men than in women. Meanwhile, among the combinations of three risk factors, a clustering effect was observed in the case of the triad of abdominal obesity, high blood pressure, and hypertriglyceridemia in both sexes. A clustering effect was also observed in the combination of hypertriglyceridemia, high blood pressure, and high fasting glucose in men and in the combination of hypertriglyceridemia, abdominal obesity, and low HDL-C in women. The combination of abdominal obesity, high blood pressure, and hypertriglyceridemia, which was common in both sexes in the present study, was also a prevalent clustering example in England, part of Italy, and Germany, with high reported prevalence.[@b24-jomes-27-166] In the current study, the combinations with clustering effects were diverse; however, all included hypertriglyceridemia. Previous studies[@b25-jomes-27-166],[@b26-jomes-27-166] have reported that the combination of abdominal obesity and hypertriglyceridemia is most applicable for predicting the risk of type 2 diabetes mellitus and cardiovascular risk. Similar to these past studies, the importance of these two risk factors, especially hypertriglyceridemia, was identified. Notably, the mechanism for their importance was unclear but appeared to be the result of free fatty acid metabolism in the liver. We assumed that increased visceral fat in abdominal obesity promotes the secretion of triglycerides in the liver, resulting in insulin resistance.[@b27-jomes-27-166] In other words, insulin resistance was initially induced by abdominal obesity, but there is an intermediate step of hypertriglyceridemia. Consequently, combinations including hypertriglyceridemia were more often observed in clustering, and the prevalence of metabolic syndrome was higher in those combinations. Thus, subjects with hypertriglyceridemia, regardless of sex, should be managed appropriately to reduce their risk of metabolic syndrome.

While hypertriglyceridemia was the most influential factor in both sexes, the second most influential factor was different between men and women, as follows: high blood pressure in men and abdominal obesity in women. A previous meta-anlysis[@b28-jomes-27-166] reported similar results in that hypertension was the most prevalent factor of metabolic syndrome in men, while the most prevalent factor of metabolic syndrome for women was central obesity. One animal study[@b29-jomes-27-166] reported that females were protected from the renin--angiotensin system by central estrogen and its regulation. In addition, a protective effect of female sex hormones was explained by chronic inflammation.[@b30-jomes-27-166] Estrogen receptors are located on the surface of immune cells and could regulate the immune response; thus, estrogen might play an important role in inducing an anti-inflammatory reaction to protect against hypertension and, through this, could lead to a sex difference regarding metabolic clustering.

The strength of this study was its use of representative data from Korea. However, there are several limitations. First, this study was cross-sectional in nature and thus cannot reveal causality. Second, because health behaviors were investigated using questionnaires, there was a risk of subjective answer. Third, the quality of the health behaviors could not be measured.

In conclusion, the health behaviors that affected metabolic syndrome in men and women were drinking alcohol more than twice a week and exercising more than four times a week, respectively; in addition, hypertriglyceridemia most significantly influenced the clustering effect of metabolic syndrome.
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###### 

Characteristics of the study population

  Variable                                 Male (n=2,101)   Female (n=2,831)                  
  ---------------------------------------- ---------------- ------------------ -------------- ------------
  Age (yr)                                                                                    
   20--39                                  588 (28.0)       35.9--42.2         810 (28.6)     33.0--38.5
   40--59                                  792 (37.7)       39.9--45.4         1,116 (39.4)   40.0--44.9
   ≥60                                     721 (34.3)       16.5--20.4         905 (32.0)     19.6--24.3
                                                                                              
  Smoking                                                                                     
   Current smoker                          794 (37.8)       37.6--42.7         127 (4.5)      3.9--6.3
   Ex-smoker                               741 (35.3)       27.2--32.2         140 (4.9)      4.6--6.6
   Nonsmoker                               416 (19.8)       20.4--24.9         2,419 (85.4)   82.1--86.2
   Other                                   150 (7.1)        6.3--9.4           145 (5.1)      4.2--6.6
                                                                                              
  Exercise                                                                                    
   Less than 3 days per week               895 (42.6)       38.9--44.3         1,201 (42.4)   39.1--43.9
   More than 4 days per week               416 (19.8)       19.5--23.7         726 (25.6)     24.0--28.2
   No                                      574 (27.3)       23.4--27.9         674 (23.8)     21.8--25.8
   Other                                   216 (10.3)       9.4--13.5          230 (8.1)      7.2--10.4
                                                                                              
  Alcohol drinking                                                                            
   No                                      235 (11.2)       7.9--10.6          508 (17.9)     15.1--18.5
   Less than once per week                 897 (42.7)       42.8--49.0         1,430 (50.5)   50.8--55.7
   More than twice per week                709 (33.7)       30.4--35.7         303 (10.7)     10.2--13.0
   Other                                   260 (12.4)       10.4--13.7         590 (20.8)     16.6--20.6
                                                                                              
  Perceived stress                                                                            
   Severe                                  413 (19.7)       19.8--23.8         706 (24.9)     24.1--28.1
   Moderate                                1,157 (55.1)     53.4--58.4         1,516 (53.5)   51.8--56.3
   Mild                                    380 (18.1)       12.9--16.5         464 (16.4)     13.3--16.0
   Other                                   151 (7.2)        6.4--9.4           145 (5.1)      4.2--6.6
                                                                                              
  Frequency of abnormal metabolic factor                                                      
   WC ≥90 cm (M) or 80 cm (F)              583 (27.7)       24.6--28.8         1,150 (40.6)   34.0--39.7
   Sys ≥130 mmHg or Dia ≥85 mmHg           932 (44.4)       35.6--41.0         922 (32.6)     24.7--29.0
   FBG ≥100 mg/dL                          487 (23.2)       17.5--21.4         415 (14.7)     11.3--13.9
   TG ≥150 mg/dL                           947 (45.1)       42.0--47.0         806 (28.5)     22.6--26.2
   HDL-C \<40 mg/dL (M) or 50 mg/dL (F)    447 (21.3)       18.0--21.8         957 (33.8)     29.9--33.9
                                                                                              
  No. of metabolic factors                                                                    
   0                                       509 (24.2)       26.6--31.2         927 (32.7)     34.9--39.9
   1                                       555 (26.4)       23.5--28.1         670 (23.7)     22.6--26.0
   2                                       496 (23.6)       20.3--24.0         520 (18.4)     16.2--19.8
   3                                       357 (17.0)       14.1--17.5         393 (13.9)     10.5--13.2
   4                                       142 (6.8)        5.1--7.5           244 (8.6)      5.6--7.5
   5                                       42 (2.0)         0.9--1.8           77 (2.7)       1.7--2.8
                                                                                              
  Presence of metabolic syndrome           541 (25.7)       21.4--25.3         714 (25.2)     18.8--22.2

Unweighted count.

CI, confidence interval; WC, waist circumference; M, male; F, female; Sys, systolic blood pressure; Dia, diastolic blood pressure; FBG, fasting blood glucose; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol.

###### 

The relations of health behaviors and metabolic factors with number of metabolic factors

  Health risk factor                                             Male    Female                 
  -------------------------------------------------------------- ------- -------------- ------- --------------
  Health behavior[\*](#tfn3-jomes-27-166){ref-type="table-fn"}                                  
   Smoking                                                                                      
    Current smoker                                               1.61    1.27--2.04     1.52    0.94--2.45
    Ex-smoker                                                    1.24    0.94--1.62     1.13    0.73--1.74
    Nonsmoker                                                    1.00                   1.00    
   Exercise                                                                                     
    Less than 3 days per week                                    1.06    0.83--1.36     0.88    0.71--1.08
    More than 4 days per week                                    0.85    0.69--1.05     0.81    0.66--0.99
    No                                                           1.00                   1.00    
   Alcohol drinking                                                                             
    Less than once per week                                      1.20    0.87--1.66     0.96    0.74--1.25
    More than twice per week                                     1.87    1.33--2.62     1.03    0.75--1.40
    None                                                         1.00                   1.00    
   Perceived stress                                                                             
    Severe                                                       1.12    0.80--1.55     0.88    0.66--1.16
    Moderate                                                     1.05    0.81--1.36     0.97    0.79--1.19
    Mild                                                         1.00                   1.00    
                                                                                                
  Metabolic factor[†](#tfn4-jomes-27-166){ref-type="table-fn"}                                  
   WC                                                                                           
    ≥90 cm (M) or 80 cm (F)                                      16.19   12.89--20.32   21.14   17.15--26.06
    Normal                                                       1.00                   1.00    
   Hypertension                                                                                 
    Sys ≥130 mmHg or Dia ≥85 mmHg                                10.93   9.20--12.99    9.71    7.83--12.03
    Normal                                                       1.00                   1.00    
   Hyperglycemia                                                                                
    FBG ≥100 mg/dL                                               12.02   9.56--15.12    18.46   14.18--24.04
    Normal                                                       1.00                   1.00    
   High TG                                                                                      
    TG ≥150 mg/dL                                                28.39   22.15--36.39   27.41   21.97--34.19
    Normal                                                       1.00                   1.00    
   Low HDL-C                                                                                    
    HDL-C \<40 mg/dL (M) or 50 mg/dL (F)                         10.33   8.34--12.79    16.05   13.21--19.49
    Normal                                                       1.00                   1.00    

Ordinary regression; subpopulation: sex=male/female, dependent variable: number of metabolic factors (ascending), model: smoking, exercise, alcohol drinking, and perceived stress, with covariance of age. Link function: logit;

Ordinary regression; subpopulation: sex=male/female, dependent variable: number of metabolic factors (ascending), model: one metabolic factor among WC, hypertension, hyperglycemia, high triglycerides, and low HDL-C, with covariance of age. Link function: logit.

CI, confidence interval; WC, waist circumference; M, male; F, female; Sys, systolic blood pressure; Dia, diastolic blood pressure; FBG, fasting blood glucose; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol.

###### 

The influence of health behaviors and metabolic factors on prevalence of metabolic syndrome

  Variable                                                       Male    Female                 
  -------------------------------------------------------------- ------- -------------- ------- --------------
  Health behavior[\*](#tfn6-jomes-27-166){ref-type="table-fn"}                                  
   Smoking                                                                                      
    Current smoker                                               1.25    0.89--1.75     1.37    0.80--2.35
    Ex-smoker                                                    1.12    0.75--1.67     1.31    0.68--2.50
    Nonsmoker                                                    1.00                   1.00    
   Exercise                                                                                     
    Less than 3 days per week                                    1.16    0.84--1.58     1.07    0.80--1.43
    More than 4 days per week                                    1.03    0.68--1.57     0.77    0.60--0.98
    No                                                           1.00                   1.00    
   Alcohol drinking                                                                             
    Less than once per week                                      0.99    0.66--1.46     0.93    0.67--1.28
    More than twice per week                                     1.66    1.12--2.46     0.84    0.54--1.31
    None                                                         1.00                   1.00    
   Perceived stress                                                                             
    Severe                                                       1.07    0.71--1.61     0.98    0.70--1.38
    Moderate                                                     0.97    0.70--1.34     0.93    0.73--1.71
    Mild                                                         1.00                   1.00    
                                                                                                
  Metabolic factor[†](#tfn7-jomes-27-166){ref-type="table-fn"}                                  
   WC                                                                                           
    ≥90 cm (M) or 80 cm (F)                                      13.54   10.21--17.94   14.29   11.02--18.53
    Normal                                                       1.00                   1.00    
   Hypertension                                                                                 
    Sys ≥130 mmHg or Dia ≥85 mmHg                                9.69    7.58--12.38    7.10    5.37--9.40
    Normal                                                       1.00                   1.00    
   Hyperglycemia                                                                                
    FBG ≥100 mg/dL                                               11.11   8.39--14.71    14.97   10.67--21.01
    Normal                                                       1.00                   1.00    
   High TG                                                                                      
    TG ≥150 mg/dL                                                17.01   12.20--23.73   22.97   17.25--30.59
    Normal                                                       1.00                   1.00    
   Low HDL-C                                                                                    
    HDL-C \<40 mg/dL (M) or 50 mg/dL (F)                         7.39    5.63--9.71     9.88    7.62--12.83
    Normal                                                       1.00                   1.00    

Logistic regression; subpopulation: sex=male/female, dependent variable: presence of metabolic syndrome (reference category=normal), model: one factor among smoking, exercise, alcohol drinking, perceived stress, and age;

Logistic regression; subpopulation: sex=male/female, dependent variable: presence of metabolic syndrome (reference category=normal), model: one factor among WC, hypertension, hyperglycemia, high triglyceride, low HDL-C with covariance of age.

OR, odds ratio; CI, confidence interval; WC, waist circumference; M, male; F, female; Sys, systolic blood pressure; Dia, diastolic blood pressure; FBG, fasting blood glucose; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol.

###### 

The clustering effects of metabolic factors in metabolic syndrome

  No. of metabolic factors   Abnormal metabolic factor   Male   Female                                                                                
  -------------------------- --------------------------- ------ -------- ---- ---------- --------- ------------ ------------- ---------- ------------ --------------
  1                          \+                          −      −        −    −          3.8/5.9   0.65         0.51--0.82    8.4/12.2   0.69         0.58--0.82
  −                          \+                          −      −        −    9.0/10.1   0.89      0.77--1.03   4.9/7.6       0.65       0.53--0.79   
  −                          −                           \+     −        −    2.0/3.9    0.50      0.36--0.70   0.8/3.0       0.28       0.18--0.42   
  −                          −                           −      \+       −    8.2/13.0   0.63      0.52--0.77   2.1/6.7       0.31       0.24--0.40   
  −                          −                           −      −        \+   2.7/4.0    0.68      0.48--0.95   8.0/9.7       0.82       0.71--0.94   
                                                                                                                                                      
  2                          \+                          \+     −        −    −          2.3/3.7   0.64         0.47--0.87    3.6/4.4    0.81         0.64--1.01
  \+                         −                           \+     −        −    0.6/1.4    0.40      0.21--0.75   0.9/1.7       0.50       0.33--0.78   
  \+                         −                           −      \+       −    3.6/4.7    0.76      0.56--1.01   1.9/3.9       0.50       0.35--0.69   
  \+                         −                           −      −        \+   0.6/1.5    0.41      0.23--0.75   4.6/5.7       0.81       0.66--1.00   
  −                          \+                          \+     −        −    1.7/2.4    0.69      0.51--0.94   0.7/1.1       0.64       0.40--1.04   
  −                          \+                          −      \+       −    6.0/8.1    0.74      0.62--0.89   1.6/2.5       0.66       0.47--0.93   
  −                          \+                          −      −        \+   0.9/2.5    0.35      0.20--0.61   1.4/3.6       0.38       0.26--0.56   
  −                          −                           \+     \+       −    2.1/3.1    0.68      0.49--0.94   0.2/1.0       0.17       0.05--0.59   
  −                          −                           \+     −        \+   0.4/1.0    0.37      0.18--0.79   0.4/1.4       0.31       0.17--0.56   
  −                          −                           −      \+       \+   4.0/3.2    1.24      0.97--1.60   2.6/3.1       0.83       0.63--1.10   
                                                                                                                                                      
  3                          \+                          \+     \+       −    −          1.2/0.9   1.34         0.84--2.15    0.9/0.6    1.40         0.90--2.17
  \+                         \+                          −      \+       −    4.4/2.9    1.49      1.17--1.88   2.4/1.4       1.66       1.29--2.14   
  \+                         \+                          −      −        \+   0.5/0.9    0.57      0.30--1.09   1.7/2.1       0.81       0.62--1.06   
  \+                         −                           \+     \+       −    1.2/1.1    1.04      0.69--1.56   0.6/0.6       1.01       0.58--1.78   
  \+                         −                           \+     −        \+   0.4/0.3    1.10      0.46--2.62   0.7/0.8       0.85       0.49--1.49   
  \+                         −                           −      \+       \+   1.6/1.2    1.40      1.00--1.94   3.2/1.8       1.73       1.37--2.19   
  −                          \+                          \+     \+       −    3.2/1.9    1.62      1.22--2.16   0.5/0.4       1.33       0.79--2.23   
  −                          \+                          \+     −        \+   0.3/0.6    0.42      0.21--0.83   0.5/0.5       0.93       0.47--1.84   
  −                          \+                          −      \+       \+   2.0/2.0    1.01      0.71--1.43   1.1/1.1       0.99       0.71--1.37   
  −                          −                           \+     \+       \+   1.1/0.8    1.41      0.90--2.21   0.3/0.4       0.72       0.37--1.39   
                                                                                                                                                      
  4                          \+                          \+     \+       \+   −          2.1/0.7   3.01         2.21--4.09    1.3/0.2    6.28         4.76--8.27
  \+                         \+                          \+     −        \+   0.4/0.2    1.86      0.88--3.91   0.8/0.3       2.68       1.88--3.82   
  \+                         \+                          −      \+       \+   2.1/0.7    2.86      2.04--3.99   2.6/0.7       3.85       3.03--4.90   
  \+                         −                           \+     \+       \+   0.6/0.3    2.12      1.22--3.67   1.1/0.3       4.37       3.04--6.27   
  −                          \+                          \+     \+       \+   1.0/0.5    2.11      1.35--3.30   0.7/0.2       4.19       2.49--7.06   
                                                                                                                                                      
  5                          \+                          \+     \+       \+   \+         1.3/0.2   7.36         5.27--10.25   2.2/0.1    22.83        17.69--29.42

WC, waist circumference; HP, hypertension; Glu, hyperglycemia; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; O/E, ratio of observed prevalence to expected prevalence; CI, confidence interval.
